Viewing StudyNCT00311480



Ignite Creation Date: 2024-05-05 @ 4:47 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00311480
Status: COMPLETED
Last Update Posted: 2007-03-13
First Post: 2006-04-04

Brief Title: Safety and Immunogenicity of Two Doses Administered Three Weeks Apart of TwoSurface Antigen Adjuvanted With MF59C1 Influenza Vaccines in Non-Elderly Adult and Elderly Subjects
Sponsor: Novartis
Organization: Novartis

Organization Data

Organization: Novartis
Class: INDUSTRY
Study ID: V87P1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Novartis
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Novartis Vaccines INDUSTRY